Last reviewed · How we verify
NCT04367350
Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
trial testing laboratory biomarkers in COVID in 500 participants. Status unknown.
31 March 2021
Quick facts
| Lead sponsor | University Hospital Tuebingen |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 500 |
| Start date | 20 March 2020 |
| Primary completion | 31 March 2021 |
| Estimated completion | 31 March 2022 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- laboratory biomarkers
- muscle ultrasound
Conditions studied
- COVID — all drugs for COVID →
- Sars-CoV2 — all drugs for Sars-CoV2 →
- Corona Virus Infection — all drugs for Corona Virus Infection →
- Myositis — all drugs for Myositis →
Sponsor
University Hospital Tuebingen
Who can join
18 and older, any sex, with COVID or Sars-CoV2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective registry for multimodal assessment of neuromuscular pathology associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, enrolling consecutive patients with corona virus disease 2019 (Covid-19), who are admitted to the intensive care unit of the department of anesthesiology and intensive care medicine, or the department of neurology at Tübingen University Hospital.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Neuropsychiatric Disorders and COVID-19: What We Know So Far.
Majolo F, Silva GLD, Vieira L, Anli C, et al · · 2021 · cited 12× · PMID 34577633 · DOI 10.3390/ph14090933 -
Neurological manifestations of COVID-19: A brief review.
Sachdev K, Agrawal S, Ish P, Gupta N, et al · · 2020 · cited 7× · PMID 32859864 · DOI 10.4103/ijmr.ijmr_1395_20
Verify or expand the search:
- PubMed search for NCT04367350
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID
Currently open trials in the same condition.
- NCT06744660 — Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test · NA · recruiting
- NCT04910269 — Outpatient Treatment With Anti-Coronavirus Immunoglobulin · Phase 3 · recruiting
- NCT04447833 — Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome · Phase 1 · active not recruiting
- NCT04351347 — The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment · Phase 2, PHASE3 · recruiting
- NCT04382846 — Novel Regimens in COVID-19 Treatment · Phase 3 · recruiting
Other University Hospital Tuebingen trials
Trials by the same sponsor.
- NCT07378670 — DEfeating PEnile CAncer-2 · NA · recruiting
- NCT07276503 — Verification of a New Predictive Delirium Score in Adults With Elective Cardiac Valve or Bypass Surgery With Perioperati · not yet recruiting
- NCT07411365 — Dual-task Cognitive-motor Telerehabilitation in Persons With PD-MCI · NA · not yet recruiting
- NCT06953791 — Comparison of Quality of Life During a Flare of Crohn's Disease Treated With Prednisolone or aCDED With PEN in Adult Pat · Phase 2 · recruiting
- NCT07378891 — Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI) · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04367350 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital Tuebingen
- Last refreshed: 29 April 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04367350.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing